Denver, CO (PRWEB) August 16, 2008
LegalView, the number one resource for everything and anything legal on the Web, reported the details of a seemingly unstoppable marine serving in Iraq, who had twice saved the life of his commanding officer, but suffered a severe traumatic brain injury (TBI) and is now forced to return home in the spring. The marine, Douglas J. Chadwick of Clarence, N.Y., had hoped to continue to serve in Iraq to "help finish the job," but was forced home due to his severe injuries. Chadwick's brain injury symptoms included a concussion and bleeding eardrums as well as additional injuries. Chadwick has been nominated for the Bronze Star and Purple Heart, but was recently awarded the Navy and Marine Commendation Medal for valor. However, his ability to serve his country was halted because of the Iraq War's "signature injury."
TBI affects nearly 1.4 million Americans each year; however, this number can only be increasing, as it has become the signature injury of the Iraq War among soldiers returning from the Middle East. Traumatic brain injury treatments range from receiving therapy to controlling side effects through medication. Unfortunately, successful treatment of long-term TBI cases is usually difficult and individuals who have previously suffered from TBI are encouraged to locate an experienced traumatic brain injury law firm immediately to learn about the possibility of developing a brain injury lawsuit. Such a lawsuit might result in monetary compensation as an award for damages incurred.
In addition to information on traumatic brain injuries, LegalView offers an array of other legal topics that may be causing severe complications to the lives of many Americans. For example, LegalView provides information on the following information portals, which have all been updated recently: Viapro, Ketek and Cipro.
Viapro is an over-the-counter drug used to treat men's erectile dysfunction (ED) and increase sexual impotency. However, the drug, from EG Labs has been linked to severe side effects when taken with other medications containing nitrates. The Viapro recall will likely affect men who are taking medications for conditions such as diabetes, high cholesterol, heart disease and high blood pressure. Because the drug contains an undeclared ingredient, thiomethisosildenafil, it could pose severe complications for patients.
The antibiotic Ketek (telithromycin) recently underwent great controversy due to the risk of developing liver damage while taking the medication. The antibacterial drug is used to treat streptococcus, community acquired pneumonia, sinusitis, bronchitis and other upper respiratory infections. However, the U.S. Food and Drug Administration (FDA) received several complaints of the drug and began an investigation; the FDA also created strong warning labels for the medication. Patients who have taken the drug are advised to not only consult medical assistance but to locate an experienced pharmaceutical law firm to learn about details associated with a Ketek lawsuit.
Another one of the updated portal topics includes Cipro, which, similar to Ketek, is an antibiotic that treats bacterial infections among patients. Cipro belongs to the fluoroquinolones drug family, which recently received a black box warning label on all of its drugs. The medications have been associated with severe Achilles tendonitis and those taking any of the drugs should speak to their physician immediately. Additionally, to learn more about the Cipro side effects, visit http://cipro.legalview.com/.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.LegalView.com/.